Harbin Sagebot Intelligent Medical Equipment
KangDuo

Chronology
Published Feb 16, 2025
Updated Oct 8, 2026
SR2000 obtains CE marking under Regulation (EU) 2017/745 (MDR). Dec 18, 2025.
NMPA market approval for RS-2000. April 2024.
First H&N surgery preclinical paper. July, 2024.
NMPA market approval for RS-1500. April 2024.
NMPA market approval for RS-1000. June 2022.
Harbin Sagebot Intelligent Medical Equipment Co., LTD founded (Dalian, China). 2013.
The KangDuo Surgical Robot (KD-SR-1000) was a new robotic surgical platform built by Suzhou Kangduo Robot Co.,Ltd. The first step in the application in Head&Neck Surgery, a preclinical trial in porcine models, wad published in July 2024.
The company behind, Harbin Sagebot Intelligent Medical Equipment Co., LTD., a high-tech enterprise focusing on the research and development, production and sales of surgical robots, was founded in 2013, and is located in Dalian (north-east China).
The first KangDuo system (SR-1000) received market approval from the Chinese regulator (NMPA) in June 2022, allowing commercial clinical use.
It has additional devices under research:
- Spinal Endoscopic Surgical Robot
- Flexible surgical robot via urethra
- Surgical Robot Via Oral Cavity
- Cochlear Implant System Surgical Robot
The first references on the KD-SR in PubMed appeared in years 2021-2022. Those were urologic procedures: radical prostatectomy, pieloplasty and partial nephrectomy. All of the first clinical series were performed in Beijing.
The first paper on H&N robotic surgery in the International Journal of Oral Science reports the use of an animal model to perform parotidectomy, submandibular gland resection and neck dissection. A video demonstration of the procedures is downloadable. The procedures were performed with a Maryland dissector and a harmonic device.

The KD-SR is an obvious copy of the da Vinci Xi. The patient cart has three arms instead of four, but with the same design almost in every detail, including the platform and the joints. The arms are numbered “1” and “2”, and the third in the middle “C”. The console features a 3D monitor instead of a visor, and a secondary monitor on-top of the former to display additional information.
How good is the performance of the device? Or a better question, is it good enough? Whatever the answer, it is clear that that we are moving forward at an accelerated pace.
The Surgical Robot Via Oral Cavity is again a copy of the da Vinci SP (Single Port). Notably, two of the five devices are specific for Otolaryngologist – Head and Neck Surgeons, and a third (KD-SR) is similar to the device currently used for Robotic Surgery in the Head and Neck. So maybe, finally, after years of neglect, we are on focus.
Newer versions followed: SR-1500 received NMPA approval in April 2024, and SR-2000 in July 2024, expanding indications and system capabilities.
In Europe, the KANGDUO® SR2000 is currently CE marked under the Medical Device Regulation (EU) 2017/745 (MDR), allowing its commercialization within the European Union for the indications covered by its certified intended use. The current European documentation specifies minimally invasive procedures in urology, gynecology, general surgery and thoracic surgery; otorhinolaryngology/head and neck surgery is not included in the current European indication. The system has already entered clinical use in Europe, with the first procedures performed in Poland in May 2026. Therefore, although KangDuo’s manufacturer lists ENT/head and neck surgery among the broader potential applications of the platform, its present MDR-certified European indication should not be interpreted as covering H&N surgery.

J Granell
Robotic Surgeon
Prior to commencing my venture into robotic surgery, I had established a firm grounding as an oncologic surgeon. My experience encompassed a wide range of resective and reconstructive procedures, as well as proficiency in minimally invasive surgical techniques and endoscopic surgery. These acquired skills and expertise serve as fundamental pillars for achieving success in robotic surgery.
Disclaimer and Accuracy Statement
All medical information provided on headneckroboticsurgery.com is uploaded and reviewed by a qualified medical doctor with the utmost care and in good faith. The content is accurate, up-to-date, and intended to offer valuable insights for both health professionals and patients. Specific update dates are noted to ensure transparency and relevance.
If you come across any information that you believe to be inaccurate or outdated, please do not hesitate to contact us directly. We are committed to maintaining the highest standards of accuracy and promptly addressing any concerns.
Related posts (in this web)
KangDuo enters the European market Oct 8, 2026.
KangDuo Surgical Robot. What is happening in China? July 14, 2024.
References
Ma Z, Guo Z, Ding Z, Cao C, He J, Tang H, Hua Y, Hong J, Shen Q, Lubamba GP, Wang X, Yang Z, Zhu G, Li C. Evaluation of a newly developed oral and maxillofacial surgical robotic platform (KD-SR-01) in head and neck surgery: a preclinical trial in porcine models. Int J Oral Sci. 2024 Jul 10;16(1):51. doi: 10.1038/s41368-024-00318-8. PMID: 38987554; PMCID: PMC11237157.
Fan S, Dai X, Yang K, Xiong S, Xiong G, Li Z, Cheng S, Li X, Meng C, Guan H, Huang Y, Mu L, Cui L, Zhou L, Li X. Robot-assisted pyeloplasty using a new robotic system, the KangDuo-Surgical Robot-01: a prospective, single-centre, single-arm clinical study. BJU Int. 2021 Aug;128(2):162-165. doi: 10.1111/bju.15396s. J Robot Surg. 2024 Jun 29;18(1):272. doi: 10.1007/s11701-024-02012-7.
